Fig. 3
From: MFG-E8 (LACTADHERIN): a novel marker associated with cerebral amyloid angiopathy
MFG-E8 immunodetection in cortical brain sections from CAA patients and controls. a Representative images of brain Aβ and MFG-E8 presence in consecutive cortical brain sections from CAA patients or control individuals. b Distribution of MFG-E8 staining according to (I) the presence or absence of CAA pathology and according to the (II) vascular and (III) parenchymal Aβ pathological burden. The graph shows the percentage of cases in each group. 0: No staining; 1: mild detection (1–50 positive deposits); 2: moderate detection (51–100); 3: intense detection (> 100 deposits) in the selected area for each section